» Articles » PMID: 9373118

Ocular Rosacea: Patient Characteristics and Follow-up

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 1997 Dec 31
PMID 9373118
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this report is to review the presenting symptoms and signs, treatment regimens used, complications encountered, and outcome in a cohort of patients with ocular rosacea.

Methods: The medical records of 131 patients with a diagnosis of ocular rosacea were reviewed retrospectively. Data were entered in a tabulated form, and a descriptive analysis was performed.

Results: The age range at presentation was between 23 and 85 years (mean, 56 years). Cutaneous manifestations of rosacea were present in 112 of the patients at their first visit. The most common presenting symptoms were foreign body sensation and burning, and the most common signs were telangiectasia and irregularity of lid margins, and meibomian gland dysfunction. Thirteen patients had decreased visual acuity at the time of presentation due to corneal complications. Six of these patients required penetrating keratoplasty during the course of their disease. Seven patients had severe cicatrizing conjunctivitis at the time of referral. One hundred thirteen patients were treated with oral tetracycline derivatives. Seven patients were left with visual acuity less than 20/400, and one patient underwent enucleation for corneal perforation and endophthalmitis.

Conclusions: Ocular rosacea is a common disease involving the skin and the eyes. It is widely underdiagnosed by many ophthalmologists despite the blinding potential. Successful therapy requires a multidisciplinary approach.

Citing Articles

Ocular Rosacea: An Updated Review.

Mohamed-Noriega K, Loya-Garcia D, Vera-Duarte G, Morales-Wong F, Ortiz-Morales G, Navas A Cornea. 2025; 44(4):525-537.

PMID: 39808113 PMC: 11872267. DOI: 10.1097/ICO.0000000000003785.


Living with your biome: how the bacterial microbiome impacts ocular surface health and disease.

Lai J, Rigas Y, Kantor N, Cohen N, Tomlinson A, St Leger A Expert Rev Ophthalmol. 2024; 19(2):89-103.

PMID: 38764699 PMC: 11101146. DOI: 10.1080/17469899.2024.2306582.


Assessment by the Scheimpflug imaging system of corneal clarity and anterior segment properties in rosacea patients.

Bozali E, Yalinbas Yeter D, Tosun M, Apa A An Bras Dermatol. 2024; 99(4):513-519.

PMID: 38614939 PMC: 11221138. DOI: 10.1016/j.abd.2023.07.005.


Rosacea Meibomian Gland Dysfunction Posterior Blepharitis May Be a Marker for Earlier Associated Dyslipidaemia and Inflammation Detection and Treatment with Statins.

Ooi K, Watson S Metabolites. 2023; 13(7).

PMID: 37512518 PMC: 10384312. DOI: 10.3390/metabo13070811.


Preferred practice patterns and review on rosacea.

Patel N, Gupta N, Shetty R Indian J Ophthalmol. 2023; 71(4):1382-1390.

PMID: 37026270 PMC: 10276755. DOI: 10.4103/IJO.IJO_2983_22.